Ironwood Pharma Says FDA Approves Use Of LINZESS In Pediatric Patients 2 Years Of Age And Older With Functional Constipation
Ironwood Pharmaceuticals Inc IRWD
$3.58
▼ -0.56%
($-0.02)
Open
$3.64
Prev Close
$3.60
Day Range
$3.50 – $3.67
52W Range
$0.56 – $5.78
Market Cap
$587.67M
P/E (TTM)
5.69
Beta
0.24
EPS (TTM)
$0.58
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2010-02-03 |
| Shares Out. | 164,610,000 |
| Website | ironwoodpharma.com/ ↗ |
| Phone | 13026587581 |
Ironwood Pharmaceuticals Inc is a publicly traded company under the ticker symbol IRWD on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-05-01)